Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancerAndrew H. Sims, Simon P. Langdon|British Journal of Cancer|2012Cited by 49
Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic functionKirsteen J. Campbell, Stephen W. G. Tait, Matthew L. Winder et al.|Cell Death and Differentiation|2021Cited by 49